Collagen Corp., LipoMatrix Inc. deal

Responding to a potential bid for LipoMatrix, CGEN agreed to buy a controlling interest in the Neuchatel, Switzerland, manufacturer of the Trilucent breast implant for $18 million.

CGEN, which co-founded LipoMatrix in 1992, currently owns 40 percent of LipoMatrix on a fully diluted basis. Following the purchase, which is expected to close on Jan. 3, CGEN will own 90 percent of LipoMatrix. The shares are currently owned by individual investors and four venture capital groups. ...